Fibrinolysis and fibrinogenolysis treatment

Details Fibrinolysis and fibrinogenolysis treatment Fibrinolysis and fibrinogenolysis treatment

1993-10-06

1995-04-18

Knode, Marian C.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424529, 424530, 424531, 514709, A61K 37547, A61K 37553, A61K 3110

Patent

active

054076730

ABSTRACT:
Disclosed is a fibrinolysis and fibrinogenolysis treatment which includes parenterally introducing into the body of a human patient human plasmin in fibrinolytically and fibrinogenolytically active form at a concentration and for a time sufficient to permit fibrinolytically and fibrinogenolytically active human plasmin to reach a concentration about the site of any intravascular clot sufficient to lyse the clot and/or to reduce circulating fibrinogen levels.

REFERENCES:
patent: Re32271 (1986-10-01), Husain et al.
patent: 3950513 (1976-04-01), Jensen
patent: 4051011 (1977-09-01), Miyauchi et al.
patent: 4083961 (1978-04-01), Dussourdd'Hinterland et al.
patent: 4245051 (1981-01-01), Reich et al.
patent: 4462980 (1984-07-01), Diedrichsen et al.
patent: 4774087 (1988-09-01), Wu et al.
patent: 4929560 (1990-05-01), Edmunds et al.
Lehringer et al., Principles of Biochemistry, Worth Publishers, Inc., New York, N.Y., 1982. pp. 100-101.
Ambrus et al., The Pharmacologist, 1:57 (1959).
Amris et al., Danish Medical Bulletin, 11:146-152 (1964).
Amris et al. Scand. J. Clin. & Lab. Investigation, 15:179-188 (1963).
Amris et al., Scand. J. Clin. & Lab. Investigation, 18:1-33 (1966).
Back et al., Circulation Research, IV:440-443 (1956).
Back et al., J. Clin. Invest., 37:864-871 (1958).
Cliffton, J. Am. Geriatrics Soc., 6:118-127 (1958).
Cook et al., Trends in Pharmaceutical Sciences, 11:444-451 (1990).
Dano et al., Biochim. Biophys. Acta., 566:138--151 (1979).
Duckert et al., in New Concepts in Streptokinase Dosimetry, Martin, Schoop & Hirsh, eds., Hans Huber Publishers, Bern-Stuttgart, 1978, pp. 175-178.
Edy et al., Thrombosis Research, 8:513-518 (1976).
Evans, C. H. in Biochemistry of the Lanthanides, Plenum Press, New York, pp. 85-125, 1990.
Hedner et al., Blood, 51:157-164 (1978).
Hirsh, in: New Concepts in Streptokinase Dosimetry, Martin, Schoop & Hirsh, eds. Hans Huber Publishers, Bern-Stuttgart, 1978, pp. 239-243.
Liu et al., Canadian J. Biochem., 49:1055-1061 (1971).
Marbet et al., Thromb. Haemostas., 48:187-189 (1982).
Marbet et al., Thromb. Haemostas., 48:190-195 (1982).
Marbet et al., Thromb. Haemostas., 48:196-200 (1982).
Matsuo et al., Nature, 291:590-591 (1981).
Mizutani et al., Japanese Circulation J., 51:822 (1987).
Powell et al., J. Biol. Chem., 255:5329-5335 (1980).
Shi et al., J. Biol. Chem., 263:17071-17075 (1988).
Sottrop-Jensen et al., in Progress in Chemical Fibrinolysis and Thrombolysis, vol. 3, Davidson et al., eds., Raven Press, New York, 1978, pp. 191-209.
K. Reddy and C. Wagner, Studies on the Stability of Plasmin, Chemical Abstracts, vol. 98, 1983, p. 330.
K. Takagi and Y. Yabushita, Antithrombotic Preparations for Medical Use, Chemical Abstracts, vol. 104, 1986, p. 393.
Knudson, B. S., et al., "The Journal of Biological Chemistry," vol. 261 (2), Aug. 15, 1986, pp. 10765-10771.
Silverstein, R. L., et al., "The Journal of Biological Chemistry," vol. 260 (18), Aug. 25, 1985, pp. 10346-10352.
E. E. Cliffton, "The Use Of Plasmin In Humans", Annals New York Academy of Sciences, 68:209-229 (1957).
J. Loscalzo, "An Overview of Thrombolytic Agents", Chest, vol. 97 Supplement #4, pp. 117S-123S (1990).

Affiliated with

Also associated with

Rating

Fibrinolysis and fibrinogenolysis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibrinolysis and fibrinogenolysis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinolysis and fibrinogenolysis treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-65194